Skip to content

Study · Randomized controlled trial · 2014

2 results

Impact of acute hyperglycemia on myocardial infarct size, area at risk, and salvage in patients with STEMI and the association with exenatide treatment: results from a randomized study.

Lønborg J, Vejlstrup N, Kelbæk H, Nepper-Christensen L, Jørgensen E, Helqvist S, Holmvang L, Saunamäki K, Bøtker HE, Kim WY, Clemmensen P, Treiman M, Engstrøm T

Diabetes28 Feb 2014Cited by 62 (Europe PMC)

PMID24584550 (opens in a new tab)DOI10.2337/db13-1849 (opens in a new tab)PepBankPUB-24584550
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study2

2 results from studies that gave the peptide. 2 results from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In STEMI patients with normoglycemia, exenatide increased myocardial salvage index versus placebo.

    In plain wordsIn heart attack patients with normal blood glucose, exenatide increased heart muscle salvage compared with placebo.

    Peptide
    Exenatide (exendin-4)
    Outcome
    IncreaseMyocardial salvage index
    Study

    n: not reported in source

    Comparator
    Placebo
    Outcome group
    Heart function · Cardiovascular
    Studied dose
    Dose not stated · intravenousAs given in this study (human).

    Source sentences

    Summary
    Treatment with exenatide resulted in increased salvage index both among patients with normoglycemia and hyperglycemia.
    1 context sentence
    Summary · context
    A total of 210 STEMI patients were randomized to receive intravenous exenatide or placebo before percutaneous coronary intervention.
  2. 02HumanRandomized controlled trialEfficacy outcome

    In STEMI patients with hyperglycemia, exenatide increased myocardial salvage index versus placebo.

    In plain wordsIn heart attack patients with high blood glucose, exenatide increased heart muscle salvage compared with placebo.

    Peptide
    Exenatide (exendin-4)
    Outcome
    IncreaseMyocardial salvage index
    Study

    n: not reported in source

    Comparator
    Placebo
    Outcome group
    Heart function · Cardiovascular
    Studied dose
    Dose not stated · intravenousAs given in this study (human).

    Source sentences

    Summary
    Treatment with exenatide resulted in increased salvage index both among patients with normoglycemia and hyperglycemia.
    1 context sentence
    Summary · context
    A total of 210 STEMI patients were randomized to receive intravenous exenatide or placebo before percutaneous coronary intervention.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:26 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.